Filter
682
Text search:
trials
guidelines
Featured
Recommendations
79
New Publications
115
Language
Document type
No document type
341
Guidelines
146
Studies & Reports
104
Manuals
37
Strategic & Response Plan
17
Fact sheets
15
Training Material
13
Situation Updates
3
Resource Platforms
3
Infographics
2
Brochures
1
Countries / Regions
India
39
Global
26
South Africa
21
Kenya
15
Africa
13
Uganda
8
Rwanda
8
Western and Central Europe
8
Russia
8
Malawi
7
Ukraine
7
Latin America and the Carribbean
7
Eastern Europe
7
Ethiopia
6
Ghana
6
Brazil
6
South–East Asia Region
6
Nigeria
5
Philippines
5
Sierra Leone
4
Zimbabwe
4
Tanzania
4
Bangladesh
4
USA
3
Cameroon
3
Nepal
3
Germany
3
Syria
3
Indonesia
3
Namibia
3
Botswana
3
East and Southern Africa
3
Asia
3
Senegal
2
Congo, Democratic Republic of
2
Lebanon
2
Argentina
2
Eswatini/ Swaziland
2
Colombia
2
Lesotho
2
West and Central Africa
2
Albania
2
Tajikistan
2
Kyrgyzstan
2
Portugal
2
Spain
2
Guinea
1
Liberia
1
Morocco
1
Haiti
1
Zambia
1
Turkey
1
Thailand
1
China
1
Mozambique
1
Sudan
1
North Macedonia
1
Hungary
1
Mexico
1
Sri Lanka
1
Chile
1
Middle East and North Africa
1
Western Pacific Region
1
Paraguay
1
Laos
1
Estonia
1
Kazakhstan
1
Georgia
1
Vietnam
1
Jamaica
1
Denmark
1
France
1
United Kingdom
1
Norway
1
Authors & Publishers
Publication Years
Category
Countries
160
Clinical Guidelines
112
Women & Child Health
58
Public Health
52
Key Resources
24
Pharmacy & Technologies
12
Capacity Building
8
Toolboxes
Mental Health
89
HIV
77
COVID-19
57
TB
54
AMR
28
NTDs
28
NCDs
28
Caregiver
27
Pharmacy
17
Disability
10
Ebola & Marburg
10
Rapid Response
10
Planetary Health
10
Polio
7
Malaria
7
Conflict
6
Refugee
5
Cholera
4
Zika
4
Natural Hazards
3
2.0 Rapid Response
3
Specific Hazards
2
Global Health Education
2
Health Financing Toolbox
2
Social Ethics
1
Document No. : FDA/SMC/CTD/GL-CCT/2013/01
This document provides up-to-date guidance on laboratory studies as well as smallscale (semi-field) and large-scale field trials to assess the efficacy and determine field application rates of new molluscicide products for control of schistosomiasis
...
Patients with diabetes are at increased risk of developing cardiovascular disease (CVD) with its manifestations of coronary artery disease (CAD), heart failure (HF), atrial fibrillation (AF), and stroke, as well as aortic and peripheral artery diseases. In addition, diabetes is a major risk factor f
...
WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines.
Updated risk rates for h
...
After 100 years of chemotherapy with impractical and toxic drugs, an oral cure for human African trypanosomiasis (HAT) is available: Fexinidazole. In this case, we review the history of drug discovery for HAT with special emphasis on the discovery, pre-clinical development, and operational challenge
...
MMWR: Recommendations and Reports / Vol. 62 / No. 9
Morbidity and Mortality Weekly Report
October 25, 2013
Drug Advisory Board
These guidelines have been developed specifically to address ethical issues of conducting research in children.
Confronted with the important issue of patient safety, in 2002 the Fifty-fifth World Health Assembly adopted a resolution urging countries to pay the closest possible attention to the problem and to strengthen safety and monitoring systems. In May 2004, the Fifty-seventh World Health Assembly approv
...
These guidelines for the National Pharmacovigilance and Medicine Information System in Rwanda have been developed to ensure that safe, efficacious and quality medicines are made available to all Rwandans.
The WHO Guidelines on physical activity and sedentary behaviour provide evidence-based public health recommendations for children, adolescents, adults and older adults on the amount of physical activity (frequency, intensity and duration) required t
...
These WHO guidelines which were updated in 2018, are valid for any country and suitable to local adaptations, and take account of the strength of available scientific evidence, the cost and resource implications, and patient values and preferences.
...
Updated 2017
